Tag Archives: CURR

CURE Pharmaceutical

CURE Pharmaceutical and CannaKids Announces Research Collaboration with Technion Israel Institute of Technology on Cancer-Fighting Cannabinoids

CURE Pharmaceutical and CannaKids Announces Research Collaboration with Technion Israel Institute of Technology on Cancer-Fighting Cannabinoids

OXNARD, Calif., May 31, 2017 /Weed Wire/ — CURE Pharmaceutical (OTCQB: CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today that the company’s partnership with CannaKids has entered into a strategic research collaboration with Technion Research and Development Foundation Ltd., a wholly owned subsidiary of the Technion Israel Institute of Technology, in order to research how different cannabinoid compounds within cannabis strains can be used to treat various subtypes of cancer.


Top